Dimitroulis, George http://orcid.org/0000-0002-8794-2329
Gupta, Benjamin
Wilson, Ian
Hart, Christopher
Article History
Received: 21 October 2021
Accepted: 30 January 2022
First Online: 4 February 2022
Declarations
:
: The clinical use of the subperiosteal device described in this article, otherwise referred to as the Osseoframe, has been reviewed and approved by the Epworth Hospital Ethics Board on Human research (EH2016/07) and has therefore been performed in accordance with the ethical standards laid down in the Declaration of Helsinki (as revised in Brazil 2013). The Osseoframe has been approved for clinical use by the Australian Therapeutic Goods Administration (TGA) as a Class IIb implantable medical device (ARTG listing 286266).
: All the patients have provided their consent to participate in this study.
: All the authors provide their consent to publish.
: Author (GD) holds shares in MAXONIQ, the company that manufactures the medical device described in the article. All other authors declare no competing interests.